Related Experiment Video
Updated: Jul 21, 2026
06:00
Four Temporary Waterslide Designs Adapted to Different Slope Conditions to Encourage Child Socialization in Playgrounds
Published on: December 9, 2022
Pediatric window falls: not just a problem for children in high rises
N L Vish1, E C Powell, D Wiltsek
1Division of Pediatric Emergency Medicine, Cininnati Children's Hospital, Cincinnati, OH, USA. nora.vish@cchmc.org
Summary
Window falls are a common cause of injury for Chicago preschool children. Most falls occurred from lower floors in buildings with four stories or less, indicating a need for targeted prevention strategies.
Area of Science:
- Pediatric Trauma
- Public Health Interventions
- Injury Prevention
Background:
- Window falls represent a significant cause of injury among preschool children in Chicago.
- Successful public health initiatives in other cities highlight the potential for intervention.
- Local data are crucial for developing effective prevention strategies in Chicago.
Purpose of the Study:
- To characterize housing attributes associated with pediatric window fall injuries.
- To identify the types of injuries sustained by children in Chicago from window falls.
- To inform targeted injury prevention efforts for Chicago's child population.
Main Methods:
- Retrospective review of pediatric trauma cases involving window falls (1995-2002).
- Analysis of patient demographics, fall circumstances, and injury types.
- Site visits to assess building characteristics (height, stories) and window types.
Main Results:
- Ninety cases were reviewed; the median age was 2 years, with 55% males.
- Most falls (98%) were from the third floor or lower, in buildings with four stories or less (96%).
- Head trauma and extremity fractures were the most common injuries; three fatalities and three rehabilitation discharges occurred.
Conclusions:
- Window falls can lead to severe pediatric injuries.
- In Chicago, falls commonly originate from modest heights in low-rise buildings, not high-rises.
- Prevention strategies should focus on owners and occupants of low-rise residential buildings.
Related Concept Videos
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...